Hindustan Bio Sciences Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical products. The Company is involved in the trading of drugs and medicine. The Company has manufacturing facilities for dry and liquid injectables, liquid/dry syrups, eye/ear/nasal drops, pre-filled syringes and non-sterile/sterile ointments, tablets, and capsules. Its products include tablets, capsules, drops, externels, and syrups.
HINDUSTAN BIO SCIENCES LTD. Financial Highlights
- Revenue: HINDUSTAN BIO SCIENCES LTD. reported revenue of ₹0.74 crore in FY26 vs ₹0.81 crore in FY25. It showed a decrease of 8.64% on a yearly basis.
- Operating Profit: HINDUSTAN BIO SCIENCES LTD. reported an operating loss of ₹0.08 crore in FY26 vs ₹0.10 crore in FY25. It showed a decrease of 180.00% on a year-on-year basis.
- Net Profit: HINDUSTAN BIO SCIENCES LTD. reported a net loss of ₹0.08 crore in FY26 vs ₹0.10 crore in FY25. It showed a decrease of 180.00% on a yearly basis.
HINDUSTAN BIO SCIENCES LTD. Quarterly Result Highlights
- HINDUSTAN BIO SCIENCES LTD. reported revenue of ₹0.00 crore in Mar 2026, compared with ₹0.40 crore in Dec 2025, representing a decrease of 100.00% on a quarter-on-quarter (QoQ) basis.
- HINDUSTAN BIO SCIENCES LTD. reported an operating loss of ₹0.12 crore in Mar 2026, compared with ₹0.08 crore in Dec 2025, representing a decrease of 250.00% on a quarter-on-quarter (QoQ) basis.
- HINDUSTAN BIO SCIENCES LTD. reported a loss of ₹0.12 crore in Mar 2026, compared with ₹0.08 crore in Dec 2025, reflecting a decrease of 250.00% on a QoQ basis.
- The earnings per share (EPS) of HINDUSTAN BIO SCIENCES LTD. stood at ₹0.10 during Mar 2026.